Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

By Argiro L.   Henri S.   Dessein H.   Dessein A.J.   Bourgois A.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

By Flo  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3242-3253

Elsevier

Access to resources Recommend Favorite

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH

By Argiro L.L.   Kohlstadt S.S.   Henri S.S.   Dessein H.H.   Matabiau V.V.   Paris P.P.   Bourgois A.A.   Dessein A.J.A.J.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2039-2048

Elsevier

Access to resources Recommend Favorite

DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice

By Chlichlia K.   Bahgat M.   Ruppel A.   Schirrmacher V.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 439-447

Elsevier

Access to resources Recommend Favorite

A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses

By Somani J.   Lonial S.   Rosenthal H.   Resnick S.   Kakhniashvili I.   Waller E.K.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 221-230

Elsevier

Access to resources Recommend Favorite